Moleculin Biotech Total Assets

Moleculin Biotech (MBRX) currently reports a total assets of $21M as of June 2026. That compares with $22M in the prior-year period — down 2.3% year over year. Use the charts on this page to explore Moleculin Biotech's total assets history and peer comparisons.

Moleculin Biotech's total assets decreased from $22M to $21M — a 2.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Moleculin Biotech reported $21M in total assets as of June 2026. That compares with $22M in the prior-year period — down 2.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Moleculin Biotech, and consider following MBRX for alerts when major investors trade the stock.

Moleculin Biotech is classified in the Healthcare sector. On total assets, it currently shows $21M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MBRX with unrelated industries.